REGEND003

· Regend Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGEND003, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) [Phase 1]